Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04512950
Other study ID # 0778
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date August 15, 2016
Est. completion date June 13, 2020

Study information

Verified date June 2023
Source Ottawa Hospital Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the FLUID Trial is to conduct a pragmatic, multi-centre, open label randomized cluster cross-over trial (RCT) to determine whether fluid administration with 0.9% saline as compared to Ringer's lactate decreases death or re-admission to hospital with 90 days of the index admission.


Description:

Crystalloid fluids are used extensively for acutely ill patients who are admitted to hospital. Two fluids most commonly used are 0.9% saline and Ringer's Lactate. Both are used to rehydrate patients, restore fluid volume and help stabilize blood pressure and failing organ and both have been used for several decades. Until recently, it was thought the fluids are essentially equivalent other than some minor differences related to the concentration of salt components (sodium and chloride) and buffers (Ringer's Lactate has lactate as a buffer). The safety of 0.9% saline is now being questioned due to its high chloride content and its association with the development of hyperchloremic metabolic acidosis. Until recently, the evidence base supporting the superiority of Ringer's Lactate has been derived from observational studies. Two recent pilot studies in critically ill patients comparing 0.9% saline to balanced crystalloid fluids (Ringer's lactate and/or Plasma-Lyte, another balanced crystalloid) did not detect clinical outcome differences between the fluid groups, but the trials were not powered to do so. Furthermore, two multiple period cluster cross-over studies conducted at one institution comparing 0.9% saline to balanced crystalloids (Ringer's lactate and Plasma-Lyte) in the emergency department (ED) and intensive care unit (ICU) found small differences in a composite outcome which included death, requirement for dialysis or persistent renal dysfunction, in favor of balanced crystalloids. In contrast, two large multi-centre randomized trials (BaSICS, n=11 052 and PLUS, n=5037) examined the efficacy of NS as compared with a balanced crystalloid (RL and Plasma-Lyte 148, respectively) on the primary outcome 90-day mortality. Neither of these trials detected a difference in 90-day mortality; in BaSICS, the mortality rate was 22.0% versus 21.8%; in PLUS, mortality was 27.2% versus 26.4%. Renal function did not differ between the fluid groups in either trial, although the PLUS trial was stopped early due to recruitment challenges and insufficient funding during the pandemic. In a systematic review of 13 critical care trials to January 2022 and 35 884 participants, there were no detectable differences in renal function. In low risk of bias trials, there was no significant difference in mortality for the 0.9% saline as compared with balanced crystalloid group (28.2% and 27.9%, respectively; relative risk (RR) 0.96 (95% CI 0.91 to 1.01)), nor renal function. However, authors concluded that there is a high probability balanced crystalloids reduce death since the CIs ranged from a 9% relative reduction to a 1% relative increase in death. Authors and editorialists urge the conduct of large multi-centre randomized trials, with longer-term patient centred outcomes supported by health economic evaluations to provide confirmatory evidence to guide future clinical practice and resource allocation related to these usual care crystalloid fluids. Small differences in clinical outcomes between crystalloid resuscitation fluids are highly relevant. Furthermore, small absolute differences in important clinical outcomes may translate into substantial savings to hospitals and the health care system. The FLUID trial will determine if there are differences in the clinically important outcomes of death and hospital re-admissions. FLUID is novel in its design because it is a hospital wide pragmatic cluster cross-over comparative effectiveness trial that will be conducted in both academic and community sites which will use provincial health administrative data available through the Institute of Clinical Evaluative Sciences (ICES) for all clinical data collection. Our trial will answer this fundamental fluid resuscitation question and determine if Ringer's Lactate is superior to 0.9% saline at much lower cost in comparison to an individual patient randomized controlled trial (RCT), or even a conventional cluster RCT.


Recruitment information / eligibility

Status Completed
Enrollment 140000
Est. completion date June 13, 2020
Est. primary completion date June 13, 2020
Accepts healthy volunteers No
Gender All
Age group 29 Days and older
Eligibility Inclusion Criteria: ? All adult and pediatric patients with an index admission to the participating hospitals during study periods Exclusion Criteria: - neonates - physicians may opt out of the use of the allocated study fluid for a specific patient

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Ringer's lactate
Half of the hospitals will be randomized to Ringer's Lactate for a 12 week study period; after a 2 week run-out, the study fluid will be switched to 0.9% saline for another 12 week study period, followed by a 2 week run-out.
0.9% saline
Half of the hospitals will be randomized to 0.9% saline for a 12 week study period; after a 2 week run-out, the study fluid will be switched to Ringer's Lactate for another 12 week study period, followed by a 2 week run-out.

Locations

Country Name City State
Canada Hamilton General Hospital Hamilton Ontario
Canada University Hospital London Ontario
Canada Victoria Hospital London Ontario
Canada Montfort Hospital Ottawa Ontario
Canada Queensway Carleton Hospital Ottawa Ontario
Canada The Ottawa Hospital Civic Campus Ottawa Ontario
Canada The Ottawa Hospital General Campus Ottawa Ontario

Sponsors (1)

Lead Sponsor Collaborator
Ottawa Hospital Research Institute

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other Incremental cost, life-year saved, quality-adjusted life-year (QALY) cost per life-year saved and cost per QALY gained 90 days from index hospitalization
Primary Number of participants that died or were readmitted to hospital the number of deaths or readmission to hospital 90 days from index hospital admission
Secondary Number of participants that died The number of deaths 90 days from index hospital admission
Secondary Number of participants re-admitted to hospital the number of participants re-admitted to any hospital in Ontario 90 days from index hospital admission
Secondary Number of participants that required dialysis or continuous renal replacement therapy the number of participants who required the initiation of dialysis or continuous renal
replacement therapy in the first 90 days from index hospital admission with no history of renal disease requiring dialysis in the previous 6 months
90 days from index hospital admission
Secondary Number of participants that required re-intubation in the post anesthetic care unit operative period the number of post operative participants who failed their initial extubation and required re-intubation in the post anesthetic care unit during index hospital admission
Secondary Duration of hospitalization the number of days participants were hospitalized during index admission Up to 90 Days from index hospital admission
Secondary ED visits number of index ED visits number of index ED visits within 90 days of index hospital admission
Secondary Discharged to a facility other than home number of participants discharged from index hospitalization to a facility other than home 90 days from index hospital admission
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06351475 - Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy N/A
Not yet recruiting NCT04982016 - Effects of Fluid Therapy on Microcirculatory Reactivity N/A
Completed NCT03215797 - Phenylephrine or Norepinephrine for a Better Hemodynamic Stability Phase 3
Completed NCT04536324 - The Absorption Rate of Subcutaneous Infused Fluid
Completed NCT02977390 - Passive Leg Raise Induced Stroke Volume Changes in Elderly Prior to Elective Surgery Measured by LiDCOplusTM N/A
Recruiting NCT01415284 - ED50 Determination of Hydroxyethylstarch for Treatment of Hypotension During Cesarean Section Under Spinal Anesthesia Phase 4
Completed NCT03245372 - Goal Directed Therapy Versus Standard Care in Lung Resection Surgery (GDT-thorax Study). N/A
Recruiting NCT05606536 - The Impact of Intra-operative Fluid Infusion Rate on Microcirculation N/A
Terminated NCT03553394 - Effects of Restrictive Fluid Strategy on Postoperative Oliguric Pancreatic Surgery Patients N/A
Recruiting NCT05153837 - Effect of Oral Water in Healthy Volunteers on Cardiac Output, Regional Flow and Microcirculation in Healthy Volunteers N/A
Completed NCT03323580 - Effects of Intraoperative GDFT on the Postoperative Brain Edema N/A
Completed NCT03394833 - Hemodynamic Stability During Induction of Anaesthesia N/A
Completed NCT03280953 - Assessing Fluid Responsiveness With PWTT
Not yet recruiting NCT06256120 - Effect of Fluid Regimen on Acute Kidney Injury N/A
Recruiting NCT03178578 - A Prospective Observational Study of the Expectations and Physiological Effects of Fluid Bolus Therapy
Enrolling by invitation NCT04388995 - SVV and PPV Predict Fluid Responsiveness in Mechanically Ventilated Elderly Patients Under General Anesthesia N/A
Not yet recruiting NCT06396884 - Hemodynamic Optimization During Spinal Anesthesia in the Elderly
Recruiting NCT05369559 - Mini Bolus for Fluid Challenge Responsiveness in the Emergency Department Early Phase 1
Recruiting NCT05054452 - Predicting Fluid Responsiveness in Mechanically Ventilated Critically Ill Children Using Transthoracic Echocardiography N/A
Completed NCT03060408 - Comparison of Fluid Requirements in Pancreatectomy: Laparotomy vs. Laparoscopy N/A